4//SEC Filing
Lu Lucy 4
Accession 0001104659-20-020235
CIK 0001644963other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:31 PM ET
Size
5.4 KB
Accession
0001104659-20-020235
Insider Transaction Report
Form 4
Lu Lucy
DirectorPresident, CEO
Transactions
- Award
Restricted Stock Units
2020-02-12+110,959→ 246,576 totalExercise: $0.00Exp: 2025-02-12→ Common Stock (110,959 underlying)
Footnotes (1)
- [F1]Each RSU represents the right to receive one share of common stock of Avenue Therapeutics, Inc. The RSUs vest upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.
Documents
Issuer
AVENUE THERAPEUTICS, INC.
CIK 0001644963
Entity typeother
Related Parties
1- filerCIK 0001542419
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:31 PM ET
- Size
- 5.4 KB